Skip to content
HowShorted

MEDICAL PROPERTIES TRUST INC short interest in 2018

In 2018, MEDICAL PROPERTIES TRUST INC's disclosed short interest ran from 6.91% of shares outstanding on 12 Jan 2018 to 5.00% on 31 Dec 2018, a change of -1.91 percentage points. The year's high was 7.92% on 15 Mar 2018 and its low 4.53% on 30 Nov 2018, averaging 5.65% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 14.05 days on 31 Jan 2018. Full history: MEDICAL PROPERTIES TRUST INC.

Cite this page
Plain
Wikipedia
BibTeX

By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for MEDICAL PROPERTIES TRUST INC in 2018

2018 in figures

Start of year
6.91% (12 Jan 2018)
End of year
5.00% (31 Dec 2018)
Change
-1.91 pp
High
7.92% (15 Mar 2018)
Low
4.53% (30 Nov 2018)
Average
5.65%
Highest days to cover
14.05 (31 Jan 2018)
SEC filings marked
8

Every report in 2018

MEDICAL PROPERTIES TRUST INC short interest in 2018
SettlementShort interestDays to coverFilings since previous
12 Jan 20186.91%10.41
31 Jan 20186.54%14.05
15 Feb 20187.10%8.04results (8-K)
28 Feb 20187.11%11.72
15 Mar 20187.92%12.8810-K filed
29 Mar 20186.35%7.75
13 Apr 20186.26%9.70
30 Apr 20185.58%10.23
15 May 20185.48%11.57results (8-K), 10-Q filed
31 May 20185.08%9.33
15 Jun 20185.89%11.14
29 Jun 20185.39%12.70
13 Jul 20185.04%12.29
31 Jul 20185.06%11.21
15 Aug 20184.92%9.01results (8-K), 10-Q filed
31 Aug 20184.73%10.30
14 Sep 20185.39%9.11
28 Sep 20185.00%8.66
15 Oct 20185.06%8.25
31 Oct 20184.85%7.55
15 Nov 20184.88%4.55results (8-K), 10-Q filed
30 Nov 20184.53%5.90
14 Dec 20185.50%4.40
31 Dec 20185.00%4.49

See also: MEDICAL PROPERTIES TRUST INC's full history · most shorted US stocks of 2018 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.